Literature DB >> 33777091

Case Report: Whole-Exome Sequencing With MLPA Revealed Variants in Two Genes in a Patient With Combined Manifestations of Spinal Muscular Atrophy and Duchenne Muscular Dystrophy.

Yu Xia1, Yijie Feng1, Lu Xu1, Xiaoyang Chen2, Feng Gao1, Shanshan Mao1.   

Abstract

Spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD) are two common kinds of neuromuscular disorders sharing various similarities in clinical manifestations. SMA is an autosomal recessive genetic disorder that results from biallelic mutations of the survival motor neuron 1 gene (SMN1; OMIM 600354) on the 5q13 chromosome. DMD is an X-linked disorder caused by defects in the DMD gene (OMIM 300377) on the X chromosome. Here, for the first time, we report a case from a Chinese family who present with clinical manifestations of both two diseases, including poor motor development and progressive muscle weakness. We identified a homozygous deletion in exons 7 and 8 of the SMN1 gene and a deletion in exon 50 of the DMD gene by whole-exome sequencing (WES) and multiplex ligation-dependent probe amplification (MLPA). This case expands our understanding of diagnosis for synchronous SMA and DMD and highlights the importance of various genetic testing methods, including WES, in differential diagnosis of neuromuscular diseases.
Copyright © 2021 Xia, Feng, Xu, Chen, Gao and Mao.

Entities:  

Keywords:  Duchenne muscular dystrophy; MLPA; Nusinersen (Spinraza); spinal muscular atrophy; synchronous diseases; whole-exome sequencing

Year:  2021        PMID: 33777091      PMCID: PMC7987946          DOI: 10.3389/fgene.2021.605611

Source DB:  PubMed          Journal:  Front Genet        ISSN: 1664-8021            Impact factor:   4.599


  29 in total

Review 1.  A genomic view of mosaicism and human disease.

Authors:  Leslie G Biesecker; Nancy B Spinner
Journal:  Nat Rev Genet       Date:  2013-05       Impact factor: 53.242

2.  Duchenne muscular dystrophy.

Authors:  Hannah Fox; Luke Millington; Indu Mahabeer; Henriette van Ruiten
Journal:  BMJ       Date:  2020-01-23

3.  Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy.

Authors:  Eugenio Mercuri; Basil T Darras; Claudia A Chiriboga; John W Day; Craig Campbell; Anne M Connolly; Susan T Iannaccone; Janbernd Kirschner; Nancy L Kuntz; Kayoko Saito; Perry B Shieh; Már Tulinius; Elena S Mazzone; Jacqueline Montes; Kathie M Bishop; Qingqing Yang; Richard Foster; Sarah Gheuens; C Frank Bennett; Wildon Farwell; Eugene Schneider; Darryl C De Vivo; Richard S Finkel
Journal:  N Engl J Med       Date:  2018-02-15       Impact factor: 91.245

4.  Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy.

Authors:  Jerry R Mendell; Samiah Al-Zaidy; Richard Shell; W Dave Arnold; Louise R Rodino-Klapac; Thomas W Prior; Linda Lowes; Lindsay Alfano; Katherine Berry; Kathleen Church; John T Kissel; Sukumar Nagendran; James L'Italien; Douglas M Sproule; Courtney Wells; Jessica A Cardenas; Marjet D Heitzer; Allan Kaspar; Sarah Corcoran; Lyndsey Braun; Shibi Likhite; Carlos Miranda; Kathrin Meyer; K D Foust; Arthur H M Burghes; Brian K Kaspar
Journal:  N Engl J Med       Date:  2017-11-02       Impact factor: 91.245

5.  RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges.

Authors:  Ai-Ming Yu; Young Hee Choi; Mei-Juan Tu
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

6.  Duchenne muscular dystrophy and myotonic dystrophy in the same patient.

Authors:  A L Dubrovsky; A L Taratuto; G Sevlever; M Schultz; E Pegoraro; R C Hoop; E P Hoffman
Journal:  Am J Med Genet       Date:  1995-01-30

7.  Recurrence risk due to germ line mosaicism: Duchenne and Becker muscular dystrophy.

Authors:  A T J M Helderman-van den Enden; R de Jong; J T den Dunnen; J J Houwing-Duistermaat; A L J Kneppers; H B Ginjaar; M H Breuning; E Bakker
Journal:  Clin Genet       Date:  2009-05       Impact factor: 4.438

8.  [Congenital centronuclear myopathy. Two morphological variants in one family (author's transl)].

Authors:  D Pongratz; A Weindl; W Reichl; C Koppenwallner; M Heuser; G Hübner
Journal:  Klin Wochenschr       Date:  1976-05-01

9.  Duchenne muscular dystrophy and spinal muscular atrophy type I segregating in the same family.

Authors:  A Oldfors; T Martinsson; I Tessin; J Wahlström; S Wang
Journal:  Clin Genet       Date:  1994-02       Impact factor: 4.438

Review 10.  New and emerging pharmacotherapy for duchenne muscular dystrophy: a focus on synthetic therapeutics.

Authors:  Sharon M Grages; Michael Bell; Daniel J Berlau
Journal:  Expert Opin Pharmacother       Date:  2020-03-05       Impact factor: 3.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.